CRISPR Therapeutics AG (CRSP)
46.29
-0.97
(-2.05%)
USD |
NASDAQ |
Nov 21, 16:00
46.55
+0.26
(+0.56%)
Pre-Market: 09:02
CRISPR Therapeutics Shareholders Equity (Quarterly): 1.940B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.940B |
| June 30, 2024 | 1.981B |
| March 31, 2024 | 2.084B |
| December 31, 2023 | 1.883B |
| September 30, 2023 | 1.728B |
| June 30, 2023 | 1.816B |
| March 31, 2023 | 1.855B |
| December 31, 2022 | 1.875B |
| September 30, 2022 | 1.954B |
| June 30, 2022 | 2.091B |
| March 31, 2022 | 2.245B |
| December 31, 2021 | 2.399B |
| September 30, 2021 | 2.513B |
| June 30, 2021 | 2.604B |
| March 31, 2021 | 1.805B |
| December 31, 2020 | 1.664B |
| September 30, 2020 | 1.343B |
| June 30, 2020 | 910.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 886.10M |
| December 31, 2019 | 939.42M |
| September 30, 2019 | 591.88M |
| June 30, 2019 | 367.68M |
| March 31, 2019 | 379.81M |
| December 31, 2018 | 392.20M |
| September 30, 2018 | 417.31M |
| June 30, 2018 | 265.15M |
| March 31, 2018 | 290.34M |
| December 31, 2017 | 187.83M |
| September 30, 2017 | 178.96M |
| June 30, 2017 | 197.80M |
| March 31, 2017 | 215.18M |
| December 31, 2016 | 232.85M |
| September 30, 2016 | -62.48M |
| June 30, 2016 | 135.34M |
| December 31, 2015 | -29.10M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
886.10M
Minimum
Mar 2020
2.604B
Maximum
Jun 2021
1.826B
Average
1.879B
Median
Shareholders Equity (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 15.63B |
| AC Immune SA | 154.72M |
| Addex Therapeutics Ltd | 14.07M |
| NLS Pharmaceutics Ltd | -9.268M |
| Molecular Partners AG | 164.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.256B |
| Total Liabilities (Quarterly) | 316.47M |